SITC Academy of Immuno-Oncology
The Academy of Immuno-Oncology was established by SITC to honor individuals who have launched the field of cancer immunotherapy into the breakthrough cancer treatment it is today and bring together the brightest minds in the field to continue to advance SITC, the field, and the next generation of immuno-oncologists.
SITC Medal of Honor
SITC is humbled to present the inaugural Medal of Honor to Uğur Şahin, MD and Özlem Türeci, MD for their efforts championing the development and distribution of the vaccine against COVID-19 using mRNA technology. SITC recognizes their incredible contributions to humanity and the countless lives saved.
Special Anniversary Awards
SITC's Anniversary Awards celebrate the achievements of current and future leaders in the cancer immunotherapy field. The work of these dedicated individuals that include young investigators, luminaries, leading organizations, regulatory agencies and industry seeks to propel the field forward and build a solid foundation for future advances and soon, a cure.
Young Investigator Awards
To promote growth and achievement amongst young investigators in the field of cancer biologics and to recognize excellence in SITC Annual Meeting oral abstract and poster presentations, SITC offers the "Young Investigator Awards."
For the SITC Presidential Travel Awards, four abstracts submitted in any category and authored by young investigators were selected for oral presentation during the Presidential Session of the SITC Annual Meeting. Those presenting authors not selected for the SITC Presidential Award will receive a SITC Presidential Travel Award in recognition of their achievement.
SITC Travel Awards are given to a select number early career investigators who submitted an abstract for the SITC Annual Meeting. The abstracts are judged by a committee of SITC leadership and SITC Annual Meeting organizers.
Steven A. Rosenberg, MD, PhD, Scholars Award
The SITC Steven A. Rosenberg, MD, PhD, Scholars Award was established in honor of Dr. Rosenberg. This award recognizes his many contributions to the field by supporting investigators, who are emerging leaders in immuno-oncology, focused on a novel approach to advancing the field of cancer immunotherapy.
JITC Best Paper Awards
Each year, the Journal for ImmunoTherapy of Cancer (JITC) honors several of its top authors from the past year with an award at the SITC Annual Meeting.
The JITC Best Paper Awards celebrate excellence in scientific research and are awarded to researchers demonstrating leadership in the field as well as innovation and high-quality execution and discussion in their manuscripts.
Connect-a-Colleague Top Referrer
Launched in November 2015, the Connect-a-Colleague campaign is designed to encourage members to personally reach out and invite potential members to join the society. An online tool was created for members to refer multiple potential members at a time. New members are also encouraged to indicate SITC members who referred them for membership.
- 2020 Recipients:
- Inas Abuali, MD – University of Cincinnati Medical Center
- Francesco M. Marincola, MD – Refuge Biotechnologies
- 2019 Recipient: Priscila H. Gonacalves, MD – Regeneron Pharmaceuticals
- 2018 Recipient: Francesco M. Marincola, MD – Refuge Biotechnologies
- 2017 Recipient: Francesco M. Marincola, MD – Refuge Biotechnologies
- 2016 Recipient: Laura S. Wood, RN, MSN, OCN – Cleveland Clinic Taussig Cancer Institute
Public Service Award
SITC Public Service Award honors an individual or group that has made substantial contributions to fostering and enhancing the field of cancer immunotherapy through increasing public understanding and awareness, research efforts, and/or funding for cancer immunotherapy.
- 2017 Recipient: Sean Parker – Parker Institute for Cancer Immunotherapy
Distinguished Service Award
In 2019, SITC recognized Dr. Martin “Mac” Cheever for his work establishing and directing the Cancer Immunotherapy Trials Network (CITN). The CITN designs and conducts early-stage, multicenter clinical trials of promising immunotherapy agents. Without the CITN trials and Dr. Cheever’s leadership and vision, patients would not have access to these promising experimental drugs.
- 2019 Recipient: Martin “Mac” A. Cheever, MD – Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, University of Washington
International Scholars
The World Immunotherapy Council—a collaborative group of more than 20 organizations from the U.S. and abroad with a shared interest in promoting research and translation of cancer immunotherapy—have selected the young investigators below to present during previous World Immunotherapy Council Young Investigators Symposium, part of SITC’s Annual Meeting & Pre-Conference Programs.
Technology Awards
To promote growth and achievement amongst early career investigators in advancing their cancer immunotherapy research by leveraging spatial technology platforms, SITC offers annual SITC Technology Awards